Scorpius
Kyle J. Lauterbach, MBA, PMP, currently serves as the Associate Director of Proposals at Scorpius BioManufacturing, Inc., specializing in large molecule cGMP manufacturing. Previously, at KBI Biopharma, Kyle advanced from Proposal Development Manager to Associate Director of Business Development, where responsibilities included leading the development of over 68 CDMO proposals with a cumulative sales value exceeding $230MM. Prior experience includes roles at Algenol Biofuels Inc. as R&D Project Manager, where Kyle managed cross-functional teams, and a foundational career at Amgen, ascending from Research Associate to Associate Scientist, focusing on cellular process development. Kyle holds an MBA in Marketing and Entrepreneurship from the University of Colorado Boulder, and has academic qualifications that include a BS in Biology from Emory University and experience as a Doctoral Candidate in Zoology at Michigan State University.
This person is not in any offices
Scorpius
Scorpius Biomanufacturing, Inc. is a CDMO focused on mammalian and microbial and large molecule biologics. We provide a broad array of biologic manufacturing, analytical and R&D services to pharmaceutical and biotech companies to advance their discoveries and deliver new therapies to patients from our San Antonio facilities, with a focus on offering services using American equipment, reagents, and materials.